Six More Clinical Trials Proposed For High Priority Status, But Per Case Funds For Them Not Assured
In Brief: Metcalf, Sachs, Nowell, Rowley, Elkind Win 1989 GM Award; Ray Morrison Retires
DCT Board Approves Recompetition f $4.3 Million CTEP Information System Contract
FDA Advisors Recommend Approval Of Leucovorin, Hexamethylmelamine
FDA, NCI Seek Compromise On Survival Endpoints
Trending Stories
- How Beth Carner went from six weeks left to live with stage 4 colon cancer to complete remission
- Richard Simon, NCI’s visionary biostatistician, dies at 80
- In 1971, Chris Lundy had minute odds of survival. He is now the longest living BMT recipient at the Hutch
- NCI: Cancer center communicators are key to the success of the National Cancer Plan
- As House prepares cuts for NIH, Rathmell urges Senate to protect funding in FY25
- Are we focused on the wrong risk type in genetic screening?
Breast cancer screening study shows new paths to population screening
